Keel Infrastructure, formerly Bitfarms, priced convertible senior notes at 1.250% due 2032, upsizing the deal from $350 ...

Keel Infrastructure (KEEL) has priced its public offering of 1.250% convertible senior notes due 2032 at an aggregate principal amount of $400M. Due to strong market demand, the offering was upsized ...

Keel Infrastructure Corp. (NASDAQ/TSX: KEEL), a North American digital and energy infrastructure company (“Keel” or the “Company”), today announced that it has priced its offering of $400 million ...

Keel Infrastructure Corp. (NASDAQ/TSX: KEEL), a North American digital and energy infrastructure company (“Keel” or the “Company”), today announced that it intends to offer $350 million aggregate ...

Peabody (NYSE: BTU) today announced the pricing of its offering of $225,000,000 aggregate principal amount of 0.50% ...

Celcuity Inc. (Nasdaq: CELC) ('Celcuity” or the 'Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor ...

In the realm of biotech and pharmaceuticals, fundraising often plays a pivotal role in driving innovation and progress. Biotech and pharmaceutical companies, whether private startups or established ...

Convertible instruments held steady in Q1 2025, but the terms are shifting in favor of investors. Interest rates on convertible notes rose by 200 to 300 basis points, and discount rates climbed as ...

You finally have investor interest. A couple of angels like the idea, one says “We usually do SAFEs,” another asks if you’re open to a convertible note, and suddenly you’re deep in legal blog posts at ...